Option Care Health, Inc.

OPCH Healthcare Medical Care Facilities

In the quarter to June 2026, revenue grew 1.86%, EPS grew 12.9%, free cash flow grew 112.4% and total debt rose 4.38%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

31.20 0.02 −0.06%
Market cap
$4.7B
P/E
23.5×
Fwd P/E
14.1×
Dividend yield
—
F-score
5/9
Altman Z
3.92
Beneish M
−2.38
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
24.89 18.56 23.03 35.54 36.27 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
5 6 9 6 9 6 3 5 6 5
P/S ratio
0.91 0.80 1.43 1.35 1.49 0.93 1.01 1.05 0.95 0.14
Altman Z-Score
3.92 3.42 4.05 3.67 3.49 2.37 1.78 3.10 3.14 0.18
P/FCF ratio
23.78 13.83 18.43 21.64 27.96 28.16 0.00 0.00 130.28 0.00
Altman Z″-Score (non-manufacturers)
2.97 3.04 2.92 2.46 1.86 1.36 1.03 1.95 (2.77) (3.06)
Beneish M-Score
(2.38) (2.51) (2.65) (2.54) (2.53) (2.65) (2.62) (0.01) (3.01) (2.25)
P/Operating CF
143.89 110.19 120.48 122.95 78.32 110.29 101.83 166.52 36.91 (32.55)
P/B ratio
3.89 2.83 4.32 3.85 4.35 2.79 2.57 3.38 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.08 0.94 1.59 1.55 1.76 1.27 1.54 1.31 1.19 0.61
EV/EBITDA
14.76 12.00 17.99 19.72 22.90 19.86 57.19 30.81 31.93 37.98
EV/Operating CF
23.57 14.47 18.47 22.85 29.06 30.26 89.98 103.96 57.61 (13.46)
EV/FCF
28.06 16.26 20.59 24.76 33.13 38.36 (913.83) (1,374.19) 162.83 (11.87)
Quick Ratio
0.85 1.05 1.17 1.19 1.00 0.99 1.19 1.44 1.24 0.91
Current Ratio
1.53 1.70 1.77 1.76 1.55 1.51 1.69 1.95 1.77 1.33
Net Debt/EBITDA
2.25 1.79 1.89 2.48 3.58 5.28 19.64 6.10 6.38 29.34
Debt/Assets
33.59% 32.47% 33.03% 34.19% 38.19% 42.47% 49.68% 37.77% 79.69% 74.70%
Debt/Equity
0.88 0.79 0.75 0.77 0.91 1.11 1.42 0.89 (5.67) 11.77
Asset Turnover
1.64 1.51 1.36 1.34 1.26 1.16 1.15 1.91 3.03 1.65
Operating CF/Net income
1.25 1.53 1.39 1.78 1.49 (15.77) (0.52) (3.99) 9.77 0.82
Capex/Depreciation
(0.55) (0.52) (0.57) (0.30) (0.35) (0.32) (0.45) (0.59) (0.60) (0.22)
Interest Coverage
6.19 6.56 6.14 4.46 2.85 1.03 0.00 0.84 0.62 (0.29)
ROE
15.20% 14.99% 19.03% 11.75% 12.77% (0.84%) (10.06%) (2.36%) (6.55%) 90.57%
ROA
6.04% 6.38% 8.44% 5.10% 5.14% (0.31%) (3.78%) (0.60%) 0.64% (9.13%)
ROIC
9.37% 9.57% 9.19% 6.96% 5.62% 3.39% (0.01%) 2.16% 4.85% (1.43%)
Return on Tangible Assets
36.11% 31.62% 44.77% 28.02% 38.64% (2.35%) (20.98%) (1.91%) 3.58% (68.35%)
Average Days of Receivables
30.60 29.92 32.04 34.93 35.90 39.52 51.25 58.36 17.08 42.56
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.08% 12.61% 14.12% 14.35% 15.29% 16.49% 19.89% 17.83% 18.51% 4.15%
Intangible Assets out of Total Assets
0.47 0.46 0.49 0.50 0.54 0.55 0.70 0.60 0.64 0.66
Share Based Compensation of Revenue
0.71% 0.72% 0.71% 0.43% 0.28% 0.10% 0.18% 0.11% 0.08% 0.19%
Graham Net Nets
(0.17) (0.17) (0.11) (0.14) (0.18) (0.34) (0.48) (0.18) (0.29) (3.02)
Graham Number
15.35 15.17 16.32 11.96 10.74 0.00 0.00 0.00 6.29 8.43
Earnings Yield
4.02% 5.39% 4.34% 2.81% 2.76% (0.26%) (3.29%) (11.12%) (24.18%) (39.57%)
Free Cash Flow Yield
4.20% 7.23% 5.43% 4.62% 3.58% 3.55% (0.17%) (0.09%) 0.77% (37.02%)
Revenue per Share
34.85 29.13 24.04 21.78 19.12 16.76 14.78 13.60 12.82 39.92
Operating CF per Share
1.59 1.88 2.07 1.48 1.16 0.70 0.25 0.17 0.27 (1.82)
Capex per Share
(0.25) (0.21) (0.21) (0.11) (0.14) (0.15) (0.18) (0.18) (0.17) (0.24)
Free Cash Flow per Share
1.34 1.68 1.86 1.36 1.02 0.56 0.07 (0.01) 0.09 (2.06)
Cash per Share
1.44 2.40 1.92 1.62 0.66 0.55 0.43 0.26 0.31 0.41
Shareholders Equity per Share
8.18 8.18 7.94 7.65 6.54 5.61 5.80 4.23 (0.59) 1.64
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
8.18 8.18 7.94 7.65 6.54 5.61 5.80 4.23 (0.59) 1.64
Free Cash Flow
217.14 287.79 333.17 246.86 182.94 100.52 11.19 (1.85) 13.40 (48.23)
Working Capital
435.62 542.48 475.95 428.99 250.56 222.99 228.65 227.43 81.46 43.18
Capital Expenditures
(41.31) (35.61) (38.12) (20.69) (25.63) (26.87) (28.28) (26.28) (24.47) (5.69)
Net Current Asset Value
(864.41) (694.88) (701.11) (732.49) (904.78) (974.70) (1,124.07) (357.96) (501.25) (393.28)
EV/EBIT
18.03 14.54 21.80 25.44 31.76 34.81 0.00 66.36 79.98 0.00
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Price to Operating Income
15.28 12.37 19.52 22.24 26.80 25.56 0.00 53.22 63.99 0.00
Other line items
Depreciation/Fixed assets
0.54 0.53 0.55 0.64 0.66 0.69 0.47 0.47 1.52 0.80
Cash ROIC
7.98% 9.83% 11.78% 8.99% 7.75% 4.49% 0.49% (0.16%) 3.04% (9.65%)
Accounts Receivable Turnover
12.79 12.70 11.39 11.02 10.32 9.29 7.28 9.80 18.79 9.06
Accounts Payable Turnover
7.30 7.68 8.25 9.35 9.46 9.33 8.79 11.96 21.20 10.40
Inventory Turnover
10.62 12.04 13.33 15.11 15.56 17.13 18.04 25.00 37.25 17.02
Average Days of Payables
51.20 55.94 46.88 44.92 38.33 43.94 44.89 45.19 17.42 34.91
Days of Inventory on Hand
37.70 35.55 30.11 26.60 25.13 24.63 23.53 20.04 10.05 19.60
Average Receivables
441.65 393.70 377.60 357.89 333.29 326.38 317.29 197.85 97.30 103.22
Average Payables
625.30 518.65 402.64 329.00 281.08 251.99 204.47 126.92 65.19 64.75
Average Inventory
429.64 331.07 249.14 203.69 170.85 137.24 99.61 60.69 37.10 39.57
Average Assets
3,438.76 3,319.39 3,164.99 2,951.93 2,719.18 2,618.49 2,008.88 1,015.65 604.04 567.81
Average Common Equity
1,365.32 1,412.96 1,403.89 1,280.99 1,095.81 961.28 754.83 259.04 (59.19) (57.25)

Fold the line items

Columns are period end dates